First clinical trial for anti-Abeta vaccine targeting Alzheimer’s disease-like characteristics in people with DS

18 May 2017 4:22 PM | Anonymous member (Administrator)

Currently Recruiting


AC Immune initiates new ACI-24 Phase Ib clinical trial in adults ages 35-45 years old with DS

ACI Announcement:

Down Syndrome Medical Interest Group-USA

DSMIG-USA is a 501(3)(c) Organization

Contact Us

Site Design by:  Site to be Seen

Powered by Wild Apricot Membership Software